✦ LIBER ✦
O-158 A randomized phase II ECOG trial of two dose levels of temsirolimus (CCI-779) in patients with extensive stage small cell lung cancer in remission after induction therapy
✍ Scribed by Pandya, K.; Levy, D.; Hidalgo, M.; Cohen, R.; Lee, M.; Dancey, J.; Schiller, J.; Johnson, D.
- Book ID
- 118572706
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 144 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0169-5002
No coin nor oath required. For personal study only.